Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | NRTI with a serious HLA-B*5701 hypersensitivity warning. | Backbone antiretroviral also active against hepatitis B. |
| Body system | Antivirals | Antivirals |
| Drug class | Nucleos(t)ide reverse transcriptase inhibitors | Nucleos(t)ide reverse transcriptase inhibitors |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | HIV infection (with other drugs) | HIV infection (with other drugs), Chronic hepatitis B |
| How it works | Blocks HIV from copying itself. | Blocks HIV and hepatitis B viruses from copying themselves. |
| Starts working | Weeks | Weeks |
| Half-life | About 1.5 hours (intracellular 12–26 hours) | 5–7 hours (intracellular 18–22 hours) |
| Typical adult dose | 600 mg once a day, or 300 mg twice a day. | 300 mg once a day or 150 mg twice a day for HIV; 100 mg once a day for hepatitis B. |
| Forms | Tablet, Oral solution, Combination tablets | Tablet, Oral solution, Fixed-dose combinations |
| Common side effects | Nausea, Headache, Tiredness, Diarrhoea | Headache, Nausea, Tiredness, Cough |
| Serious side effects | Abacavir hypersensitivity reaction, Heart attack signal in some studies, Lactic acidosis (rare) | Hepatitis flare on stopping in co-infected people, Lactic acidosis (rare), Pancreatitis in children |
| Don't take if | HLA-B*5701 positive; Previous reaction to abacavir; Moderate to severe liver disease | Taking emtricitabine (same class) |
| Alcohol | Best to limit. Alcohol raises abacavir levels. | Best to limit. Alcohol adds to liver strain, particularly in hepatitis B. |
| Pregnancy | Generally considered safeUsed in pregnancy within HIV regimens. | Generally considered safeWidely used in pregnancy within HIV regimens. |
| Breastfeeding | Usually avoidedNot recommended where safe formula is available. | Usually avoidedIn high-income countries breastfeeding is not advised with HIV; where formula is unsafe, guidelines support breastfeeding with treatment. |
| In use since | — | — |
| Brand names | United States: Ziagen, Triumeq (combination)United Kingdom: Ziagen, Kivexa, TriumeqIndia: Abamune, Ziagen | United States: EpivirUnited Kingdom: EpivirIndia: Lamivir, Lamivudine (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | J05AF06 | J05AF05 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker